Literature DB >> 18612777

TIG3: a regulator of type I transglutaminase activity in epidermis.

Richard L Eckert1, Michael T Sturniolo, Ralph Jans, Catherine A Kraft, Haibing Jiang, Ellen A Rorke.   

Abstract

Keratinocytes undergo a process of terminal cell differentiation that results in the construction of a multilayered epithelium designed to produce a structure that functions to protect the body from dehydration, abrasion and infection. These protective properties are due to the production of a crosslinked layer of protein called the cornified envelope. Type I transglutaminase (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl)lysine bonds, is the key protein responsible for generation of the crosslinks. The mechanisms that lead to activation of transglutaminase during terminal differentiation are not well understood. We have identified a protein that interacts with TG1 and regulates its activity. This protein, tazarotene-induced gene 3 (TIG3), is expressed in the differentiated layers of the epidermis and its expression is associated with transglutaminase activation and cornified envelope formation. We describe a novel mechanism whereby TIG3 regulates TG1 activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612777      PMCID: PMC3124850          DOI: 10.1007/s00726-008-0123-9

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  63 in total

1.  Expression of keratinocyte transglutamine mRNA revealed by in situ hybridization.

Authors:  S Michel; F Bernerd; A M Jetten; E E Floyd; B Shroot; U Reichert
Journal:  J Invest Dermatol       Date:  1992-03       Impact factor: 8.551

Review 2.  Keratinocyte transglutaminase: differentiation marker and member of an extended family.

Authors:  R H Rice; M Mehrpouyan; W O'Callahan; N L Parenteau; A L Rubin
Journal:  Epithelial Cell Biol       Date:  1992-07

3.  The complete amino acid sequence of the human transglutaminase K enzyme deduced from the nucleic acid sequences of cDNA clones.

Authors:  H C Kim; W W Idler; I G Kim; J H Han; S I Chung; P M Steinert
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

4.  Isolation of cDNA for human epidermal type I transglutaminase.

Authors:  R Polakowska; E Herting; L A Goldsmith
Journal:  J Invest Dermatol       Date:  1991-02       Impact factor: 8.551

5.  Primary structure of keratinocyte transglutaminase.

Authors:  M A Phillips; B E Stewart; Q Qin; R Chakravarty; E E Floyd; A M Jetten; R H Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Proteolytic release of keratinocyte transglutaminase.

Authors:  R H Rice; X H Rong; R Chakravarty
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

7.  Regulation of intracellular free calcium in normal murine keratinocytes.

Authors:  F H Kruszewski; H Hennings; S H Yuspa; R W Tucker
Journal:  Am J Physiol       Date:  1991-11

Review 8.  Involucrin--structure and role in envelope assembly.

Authors:  R L Eckert; M B Yaffe; J F Crish; S Murthy; E A Rorke; J F Welter
Journal:  J Invest Dermatol       Date:  1993-05       Impact factor: 8.551

9.  Structure and organization of the human transglutaminase 1 gene.

Authors:  I G Kim; O W McBride; M Wang; S Y Kim; W W Idler; P M Steinert
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

10.  Genomic structure of keratinocyte transglutaminase. Recruitment of new exon for modified function.

Authors:  M A Phillips; B E Stewart; R H Rice
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

View more
  9 in total

1.  Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.

Authors:  Micha M M Wilhelmus; Mieke de Jager; Annemieke J M Rozemuller; John Brevé; John G J M Bol; Richard L Eckert; Benjamin Drukarch
Journal:  J Pathol       Date:  2011-10-18       Impact factor: 7.996

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

3.  Protein kinase D1 deficiency promotes differentiation in epidermal keratinocytes.

Authors:  Vivek Choudhary; Lawrence O Olala; Ismail Kaddour-Djebbar; Inas Helwa; Wendy B Bollag
Journal:  J Dermatol Sci       Date:  2014-10-02       Impact factor: 4.563

Review 4.  Regulation of the activities of the mammalian transglutaminase family of enzymes.

Authors:  Cornelius Klöck; Chaitan Khosla
Journal:  Protein Sci       Date:  2012-11-09       Impact factor: 6.725

5.  C/EBPδ gene targets in human keratinocytes.

Authors:  Serena Borrelli; Daniele Fanoni; Diletta Dolfini; Daniela Alotto; Maria Ravo; Olì Maria Victoria Grober; Alessandro Weisz; Carlotta Castagnoli; Emilio Berti; M Alessandra Vigano; Roberto Mantovani
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

6.  Pericentrosomal localization of the TIG3 tumor suppressor requires an N-terminal hydrophilic region motif.

Authors:  Tiffany M Scharadin; Gautam Adhikary; Kristin Shaw; Dan J B Grun; Wen Xu; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2013-12-13       Impact factor: 8.551

7.  Tazarotene-induced gene 3 may affect inflammatory angiogenesis in psoriasis by downregulating placental growth factor expression.

Authors:  Su-Young Jeon; Seung-Min Ha; Dong-Yeob Ko; Bon-Seok Ku; Chae-Young Lee; Ki-Hoon Song; Ki-Ho Kim
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

Review 8.  TIG3: an important regulator of keratinocyte proliferation and survival.

Authors:  Tiffany M Scharadin; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2014-03-06       Impact factor: 8.551

9.  Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.

Authors:  C Kerr; H Szmacinski; M L Fisher; B Nance; J R Lakowicz; A Akbar; J W Keillor; T Lok Wong; R Godoy-Ruiz; E A Toth; D J Weber; R L Eckert
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.